Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on β-cell function in normal living conditions

被引:68
作者
Mari, Andrea
Degn, Kristine
Brock, Birgitte
Rungby, Joergen
Ferrannini, Ele
Schmitz, Ole
机构
[1] Natl Res Council Inst Biomed Engn, Padua, Italy
[2] Univ Aarhus Hosp, Dept Endocrinol & Diabet, Aarhus, Denmark
[3] Univ Pisa, Natl Res Council Inst Clin Physiol, Pisa, Italy
关键词
D O I
10.2337/dc07-0310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2032 / 2033
页数:2
相关论文
共 7 条
  • [1] The GLP-1 derivative NN2211 restores β-cell sensitivity to glucose in type 2 diabetic patients after a single dose
    Chang, AM
    Jakobsen, G
    Sturis, J
    Smith, MJ
    Bloem, CJ
    An, B
    Galecki, A
    Halter, JB
    [J]. DIABETES, 2003, 52 (07) : 1786 - 1791
  • [2] One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and α- and β-cell function and reduces endogenous glucose release in patients with type 2 diabetes
    Degn, KB
    Juhl, CB
    Sturis, J
    Jakobsen, G
    Brock, B
    Chandramouli, V
    Rungby, J
    Landau, BR
    Schmitz, O
    [J]. DIABETES, 2004, 53 (05) : 1187 - 1194
  • [3] Madsbad S, 2006, DIABETOLOGIA, V49, P4
  • [4] Mathematical modeling shows exenatide improved β-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea
    Mari, A.
    Nielsen, L. L.
    Nanayakkara, N.
    DeFronz, R. A.
    Ferrannini, E.
    Halseth, A.
    [J]. HORMONE AND METABOLIC RESEARCH, 2006, 38 (12) : 838 - 844
  • [5] Assessing insulin secretion by modeling in multiple-meal tests - Role of potentiation
    Mari, A
    Tura, A
    Gastaldelli, A
    Ferrannini, E
    [J]. DIABETES, 2002, 51 : S221 - S226
  • [6] Meal and oral glucose tests for assessment of β-cell function:: modeling analysis in normal subjects
    Mari, A
    Schmitz, O
    Gastaldelli, A
    Oestergaard, T
    Nyholm, B
    Ferrannini, E
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (06): : E1159 - E1166
  • [7] Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
    Nauck, MA
    Meier, JJ
    [J]. REGULATORY PEPTIDES, 2005, 128 (02) : 135 - 148